Related Experiment Video
Updated: May 23, 2026
09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
The apolipoprotein E polymorphism and cardiovascular diseases--an autopsy study.
Neena Theresa Kumar1, Knut Liestøl, Else Marit Løberg
1Department of Pathology, Oslo University Hospital-Ullevål, Oslo, Norway. n.t.kumar@medisin.uio.no
Summary
The apolipoprotein E (APOE) ɛ4 allele is linked to higher cardiovascular disease risk, particularly coronary and cerebrovascular diseases. Autopsy findings reveal APOE genotype influences disease development and mortality.
Area of Science:
- Genetics
- Cardiology
- Pathology
Background:
- Apolipoprotein E (APOE) polymorphism is studied for cardiovascular disease (CVD) links.
- Few studies utilize autopsy findings to investigate APOE and CVD.
- This study examines autopsy data from a general hospital population.
Purpose of the Study:
- To investigate the association between apolipoprotein E (APOE) polymorphism and cardiovascular disease using autopsy data.
- To explore the influence of APOE genotypes on atherosclerosis, myocardial infarction, and cerebrovascular disease.
Main Methods:
- Retrospective analysis of 1522 autopsy reports (1996-2000).
- Recorded cause of death, cardiovascular disease signs (atherosclerosis, myocardial infarction, cerebrovascular disease), and heart weight.
- Genotyped patients for APOE alleles (ɛ2, ɛ3, ɛ4).
Main Results:
- APOE allele frequencies in the study population were similar to controls.
- Patients dying from CVD had significantly more ɛ4-carriers and fewer ɛ2-carriers.
- ɛ4-carriers showed a trend towards increased aortic and coronary atherosclerosis.
- Higher heart weights were observed in ɛ2-carriers versus ɛ4-carriers among those with coronary heart disease.
Conclusions:
- APOE polymorphism influences the risk of developing and dying from cardiovascular diseases.
- Findings suggest APOE ɛ4 is associated with increased risk of coronary heart disease and cerebrovascular disease.
- Autopsy data provides valuable insights into the role of APOE in cardiovascular pathology.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...